Healthcare, Real Estate, Financials Apr 01, 2022 05:34 PM (GMT+8)
According to the pharmaceutical announcement, the company's bc004 for injection obtained the notice of approval for drug clinical trial. BC004 is mainly used for the treatment of HER2 positive late solid tumors, including HER2 positive breast cancer, gastric cancer / gastroesophageal junction adenocarcinoma and so on. At present, there are no drugs on the market with the same target at home and abroad.
This text is a result of machine translation.